14804-41-2

Basic information

• Product Name: 4-bromo-2,6-diisopropyl-1-methoxy-benzene
• Synonyms: 4-bromo-2,6-diisopropyl-1-methoxy-benzene
• CAS NO: 14804-41-2
• Molecular Weight: 271.197
• Mol File: 14804-41-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-bromo-2,6-diisopropyl-1-methoxy-benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2,6-diisopropyl-1-methoxy-benzene(14804-41-2)
• EPA Substance Registry System: 4-bromo-2,6-diisopropyl-1-methoxy-benzene(14804-41-2)

Safety Data

• Hazardous Substances Data: 14804-41-2(Hazardous Substances Data)

Upstream product

• 2432-03-3 4-bromopropofol 
• 616-38-6 carbonic acid dimethyl ester 
• 74-88-4 methyl iodide 

Downstream Products

• 715-71-9 4-fluoro-2,6-diisopropylanisole 
• 13860-74-7 3..3'.5'-Triisopropyl-DL-thyronin 
• 16221-03-7 Ethyl-acetamido<4-(3.5-diisopropyl-4-methoxyphenoxy)-3-isopropylbenzyl>malonat 
• 153742-22-4 dimethyl 2-(3,5-diisopropyl-4-methoxyphenyl) malonate 
• 152268-84-3 Adamantan-1-yl-(2'-bromo-3,5,3',5'-tetraisopropyl-4,4'-dimethoxy-biphenyl-2-ylethynyl)-fluoro-(2,4,6-tri-tert-butyl-phenyl)-silane 
• 16221-02-6 2,6-Diisopropyl-4-(o-isopropylphenoxy)-anisole 
• 153742-21-3 diethyl 2-(3,5-diisopropyl-4-methoxyphenyl)malonate 

Relevant articles and documents

Synthesis, structure and catalytic properties of new half-titanocene complexes bearing substituted cyclopentadienyl and aryloxide ligands

New cyclopentadienyltitanium aryloxide complexes, 1-phenyl-2,3,4,5- Me4CpTi(O-2,6-iPr2-4-nBu-C6H2)Cl2 (1) and [4,4′-biphenyl-(2,3,4,5-Me4Cp)2][Ti(O-2,6-iPr2-4- nBu-C6H2)Cl2]2 (2), have been prepared by treatment

11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho[2,3-D]thiophenes useful in the treatment of insulin resistance and hyperglycemia

This invention provides compounds of Formula I having the structure wherein A is hydrogen, halogen, or OH; B and D are each, independently, hydrogen, halogen, CN, alkyl of 1-6 carbon atoms, aryl, aralkyl of 6-12 carbon atoms, nitro, amino or OR; R is hydrogen, alkyl of 1-6 carbon atoms, -COR1, -CH2CO2R1, -CH(R1a)CO2R1, or -SO2R1; R1 and R1a are each, independently, hydrogen, alkyl of 1-6 carbon atoms, aralkyl of 6-12 carbon atoms or aryl; E is S, SO, SO2, O; X is hydrogen, halogen, alkyl of 1-6 carbon atoms, CN, perfluoroalkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, aryloxy, arylalkoxy of 6-12 carbon atoms, nitro, amino, alkylsulfanyl of 1-6 carbon atoms, arylsulfanyl, pyridylsulfanyl, 2-N,N-dimethylaminoethylsulfanyl, or -OCH2CO2R1b; R1b is hydrogen or alkyl of 1-6 carbon atoms; Y and Z are each, independently, hydrogen or OR2; R2 is hydrogen, alkyl of 1-6 carbon atoms, aralkyl of 6-12 carbon atoms, or -CH2CO2R3; R3 is hydrogen or alkyl of 1-6 carbon atoms; C is hydrogen, halogen or OR4; R4 is hydrogen, alkyl of 1-6 carbon atoms, -CH(R5)W, -C(CH3)2CO2R6, 5-thiazolidine-2,4-dione, -CH(R7)CH2CO2R6, -COR6, PO3(R6)2, or -SO2R6; R5 is hydrogen, alkyl of 1-6 carbon atoms, aralkyl, aryl, CH2(1H-imidazol-4-yl), -CH2(3-1H-indolyl), -CH2CH2(1,3-dioxo-1,3-dihydro-isoindol-2-yl), -CH2CH2(1-oxo-1,3-dihydro-isoindol-2-yl), -CH2(3-pyridyl), or -CH2CO2H; W is -CO2R6, -CONH2, -CONHOH, CN, -CONH(CH2)2CN, 5-tetrazole, -PO3(R6)2, -CH2OH, or -CH2Br, -CONR6CHR7CO2R8, R6 is hydrogen, alkyl of 1-6 carbon atoms, aryl or aralkyl; R7 is hydrogen, alkyl of 1-6 carbon atoms, aryl or aralkyl; R8 is hydrogen, alkyl of 1-6 carbon atoms, aryl or aralkyl; or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.